Argyrophilic grain disease as a neurodegenerative substrate in late-onset schizophrenia and delusional disorders

European Archives of Psychiatry and Clinical Neuroscience

Volumn 264, Issue 4, 2014, Pages 317-331

  Nagao, Shigeto ^a   Yokota, Osamu ^a   Ikeda, Chikako ^a   Takeda, Naoya ^a   Ishizu, Hideki ^a,b   Kuroda, Shigetoshi ^b   Sudo, Koichiro ^c   Terada, Seishi ^a   Murayama, Shigeo ^d   Uchitomi, Yosuke ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b Zikei Institute of Psychiatry   (Japan)

^c Tosa Hospital   (Japan)

^d Tokyo Metropolitan Institute of Gerontology   (Japan)

Author keywords

Argyrophilic grain; Corticobasal degeneration; Four repeat tau; Late onset; Tauopathy; Synuclein

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARGYROPHILIC GRAIN DISEASE; ARTICLE; BIPOLAR DISORDER; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOBASAL DEGENERATION; DEGENERATIVE DISEASE; DELUSION; DELUSIONAL DISORDER; DIFFUSE LEWY BODY DISEASE; FEMALE; HUMAN; MALE; MENTAL DISEASE; NEUROSIS; PERSONALITY DISORDER; PRIORITY JOURNAL; SCHIZOPHRENIA; TEMPORAL CORTEX; BRAIN; CASE CONTROL STUDY; COMPLICATION; INTERMEDIATE FILAMENT; METABOLISM; MIDDLE AGED; NEURODEGENERATIVE DISEASES; NONPARAMETRIC TEST; ONSET AGE; PATHOLOGY; PSYCHOSIS; VERY ELDERLY;

ALPHA SYNUCLEIN; DNA BINDING PROTEIN; PROTEIN TDP-43; TAU PROTEIN;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; ALPHA-SYNUCLEIN; BRAIN; CASE-CONTROL STUDIES; DNA-BINDING PROTEINS; FEMALE; HUMANS; INTERMEDIATE FILAMENTS; MALE; MIDDLE AGED; NEURODEGENERATIVE DISEASES; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; STATISTICS, NONPARAMETRIC; TAU PROTEINS;

EID: 84903647354     PISSN: 09401334     EISSN: 14338491     Source Type: Journal    
DOI: 10.1007/s00406-013-0472-6     Document Type: Article

References (69)

1. Sadock BJ, Sadock VA (2003) Kaplan and Sadock's synopsis of psychiatry: behavioral sciences/clinical psychiatry, 9th edn. Lippincott Williams & Wilkins, Philadelphia
2. American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders, 4th edn, text revision (DSM-IV-TR), American Psychiatric Association, Washington DC
3. Bleuler M (1943) Late schizophrenic clinical pictures. Fortschr Neurol Psychiatr 15:259-290
4. Howard R, Castle D, Wessely S, Murray R (1993) A comparative study of 470 cases of early-onset and late-onset schizophrenia. Br J Psychiatry 163:352-357 (Pubitemid 23274377)
5. Howard R, Almeida O, Levy R (1994) Phenomenology, demography and diagnosis in late paraphrenia. Psychol Med 24:397-410 (Pubitemid 24158853)
6. Pearlson GD, Kreger L, Rabins PV, Chase GA, Cohen B, Wirth JB, Schlaepfer TB, Tune LE (1989) A chart review study of lateonset and early-onset schizophrenia. Am J Psychiatry 146:1568-1574 (Pubitemid 20014726)
7. Rabins P, Pauker S, Thomas J (1984) Can schizophrenia begin after age 44? Compr Psychiatry 25:290-293 (Pubitemid 14100497)
8. Riecher-Rössler A, Löffler W, Munk-Jørgensen P (1997) What do we really know about late-onset schizophrenia? Eur Arch Psychiatry Clin Neurosci 247:195-208
9. Rajji TK, Ismail Z, Mulsant BH (2009) Age at onset and cognition in schizophrenia: meta-analysis. Br J Psychiatry 195:286-293
10. Howard R, Rabins PV, Seeman MV, Jeste DV (2000) Late-onset schizophrenia and very-late-onset schizophrenia-like psychosis: an international consensus. The International Late-Onset Schizophrenia Group. Am J Psychiatry 157:172-178 (Pubitemid 30080894)
11. Alexopoulos GS, Meyers BS, Young RC, Campbell S, Silbersweig D, Charlson M (1997) 'Vascular depression' hypothesis. Arch Gen Psychiatry 54:915-922 (Pubitemid 128719702)
12. Fujikawa T, Yamawaki S, Touhouda Y (1993) Incidence of silent cerebral infarction in patients with major depression. Stroke 24:1631-1634 (Pubitemid 23315866)
13. Stewart R, Prince M, Mann A, Richards M, Brayne C (2001) Stroke, vascular risk factors and depression: cross-sectional study in a UK Caribbean-born population. Br J Psychiatry 178:23-28 (Pubitemid 32055641)
14. Thomas AJ, Ferrier IN, Kalaria RN, Perry RH, Brown A, O'Brien JT (2001) A neuropathological study of vascular factors in latelife depression. J Neurol Neurosurg Psychiatry 70:83-87 (Pubitemid 32096126)
15. Krishnan KR, McDonald WM, Doraiswamy PM, Tupler LA, Husain M, Boyko OB, Figiel GS, Ellinwood EH Jr (1993) Neuroanatomical substrates of depression in the elderly. Eur Arch Psychiatry Clin Neurosci 243:41-46 (Pubitemid 23276044)
16. Förstl H, Burns A, Luthert P, Cairns N, Lantos P, Levy R (1992) Clinical and neuropathological correlates of depression in Alzheimer's disease. Psychol Med 22:877-884 (Pubitemid 23006999)
17. Gibb WR, Esiri MM, Lees AJ (1987) Clinical and pathological features of diffuse cortical Lewy body disease (Lewy body dementia). Brain 110:1131-1153 (Pubitemid 17167996)
18. Klatka LA, Louis ED, Schiffer RB (1996) Psychiatric features in diffuse Lewy body disease: a clinicopathologic study using Alzheimer's disease and Parkinson's disease comparison groups. Neurology 47:1148-1152 (Pubitemid 26374877)
19. Tsopelas C, Stewart R, Savva GM, Brayne C, Ince P, Thomas A, Matthews FE, Medical Research Council Cognitive Function and Ageing Study (2011) Neuropathological correlates of late-life depression in older people. Br J Psychiatry 198:109-114
20. Xekardaki A, Santos M, Hof P, Kövari E, Bouras C, Giannakopoulos P (2012) Neuropathological substrates and structural changes in late-life depression: the impact of vascular burden. Acta Neuropathol 124:453-464
21. Jellinger KA (2013) Organic bases of late-life depression: a critical update. J Neural Transm 120:1109-1125
22. Jellinger KA, Gabriel E (1999) No increased incidence of Alzheimer's disease in elderly schizophrenics. Acta Neuropathol 97:165-169 (Pubitemid 29134545)
23. Jellinger KA (2009) Lewy body/alpha-synucleinopathy in schizophrenia and depression: a preliminary neuropathological study. Acta Neuropathol 117:423-427
24. Casanova MF, Stevens JR, Brown R, Royston C, Bruton C (2002) Disentangling the pathology of schizophrenia and paraphrenia. Acta Neuropathol 103:313-320 (Pubitemid 36097025)
25. Bozikas VP, Kövari E, Bouras C, Karavatos A (2002) Neurofibrillary tangles in elderly patients with late onset schizophrenia. Neurosci Lett 324:109-112 (Pubitemid 34460694)
26. Casanova MF (2003) Preservation of hippocampal pyramidal cells in paraphrenia. Schizophr Res 62:141-146
27. Birkett DP, Desouky A, Han L, Kaufman M (1992) Lewy bodies in psychiatric patients. Int J Geriatr Psychiatry 7:235-240
28. Aarsland D, Litvan I, Larsen JP (2001) Neuropsychiatric symptoms of patients with progressive supranuclear palsy and Parkinson's disease. J Neuropsychiatry Clin Neurosci 13:42-49 (Pubitemid 32151915)
29. Geda YE, Boeve BF, Negash S, Graff-Radford NR, Knopman DS, Parisi JE, Dickson DW, Petersen RC (2007) Neuropsychiatric features in 36 pathologically confirmed cases of corticobasal degeneration. J Neuropsychiatry Clin Neurosci 19:77-80 (Pubitemid 46294449)
30. Josephs KA, Dickson DW (2003) Diagnostic accuracy of progressive supranuclear palsy in the Society for Progressive Supranuclear Palsy brain bank. Mov Disord 18:1018-1026 (Pubitemid 37185209)
31. Togo T, Isojima D, Akatsu H, Suzuki K, Uchikado H, Katsuse O, Iseki E, Kosaka K, Hirayasu Y (2005) Clinical features of argyrophilic grain disease: a retrospective survey of cases with neuropsychiatric symptoms. Am J Geriatr Psychiatry 13:1083-1091 (Pubitemid 46638653)
32. Braak H, Braak E (1998) Argyrophilic grain disease: frequency of occurrence in different age categories and neuropathological diagnostic criteria. J Neural Transm 105:801-819 (Pubitemid 28539831)
33. Saito Y, Ruberu NN, Sawabe M, Arai T, Tanaka N, Kakuta Y, Yamanouchi H, Murayama S (2004) Staging of argyrophilic grains: an age-associated tauopathy. J Neuropathol Exp Neurol 63:911-918 (Pubitemid 39202494)
34. Asaoka T, Tsuchiya K, Fujishiro H, Arai T, Hasegawa M, Akiyama H, Iseki E, Oda T, Onaya M, Tominaga I (2010) Argyrophilic grain disease with delusions and hallucinations: a pathological study. Psychogeriatrics 10:69-76
35. Ikeda K, Akiyama H, Arai T, Matsushita M, Tsuchiya K, Miyazaki H (2000) Clinical aspects of argyrophilic grain disease. Clin Neuropathol 19:278-284
36. Ishihara K, Araki S, Ihori N, Shiota J, Kawamura M, Yoshida M, Hashizume Y, Nakano I (2005) Argyrophilic grain disease presenting with frontotemporal dementia: a neuropsychological and pathological study of an autopsied case with presenile onset. Neuropathology 25:165-170 (Pubitemid 40571396)
37. Maurage CA, Sergeant N, Schraen-Maschke S, Lebert F, Ruchoux MM, Sablonnière B, Pasquier F, Delacourte A (2003) Diffuse form of argyrophilic grain disease: a new variant of fourrepeat tauopathy different from limbic argyrophilic grain disease. Acta Neuropathol 106:575-583 (Pubitemid 37441615)
38. Tsuchiya K, Mitani K, Arai T, Yamada S, Komiya T, Esaki Y, Haga C, Yamanouchi H, Ikeda K (2001) Argyrophilic grain disease mimicking temporal Pick's disease: a clinical, radiological, and pathological study of an autopsy case with a clinical course of 15 years. Acta Neuropathol 102:195-199 (Pubitemid 32771670)
39. Yokota O, Davidson Y, Bigio EH, Ishizu H, Terada S, Arai T, Hasegawa M, Akiyama H, Sikkink S, Pickering-Brown S, Mann DM (2010) Phosphorylated TDP-43 pathology and hippocampal sclerosis in progressive supranuclear palsy. Acta Neuropathol 120:55-66
40. Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 112:389-404 (Pubitemid 44469160)
41. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer- related changes. Acta Neuropathol 82:239-259
42. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L (1991) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41:479-486
43. The National Institute on Aging and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease (1997) Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. Neurobiol Aging 18(4 Suppl):S1-S2
44. Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, Mirra SS, Nelson PT, Schneider JA, Thal DR, Trojanowski JQ, Vinters HV, Hyman BT, National Institute on Aging, Alzheimer's Association (2012) National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach. Acta Neuropathol 123:1-11
45. McKeith IG, Dickson DW, Lowe J et al (2005) Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65:1863-1872 (Pubitemid 43970103)
46. Uchikado H, Lin WL, DeLucia MW, Dickson DW (2006) Alzheimer disease with amygdala Lewy bodies: a distinct form of alpha-synucleinopathy. J Neuropathol Exp Neurol 65:685-697 (Pubitemid 44297259)
47. Dickson DW, Bergeron C, Chin SS, Duyckaerts C, Horoupian D, Ikeda K, Jellinger K, Lantos PL, Lippa CF, Mirra SS, Tabaton M, Vonsattel JP, Wakabayashi K, Litvan I, Office of Rare Diseases of the National Institutes of Health (2002) Office of rare diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol 61:935-946 (Pubitemid 35278715)
48. Hauw JJ, Daniel SE, Dickson D, Horoupian DS, Jellinger K, Lantos PL, McKee A, Tabaton M, Litvan I (1994) Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 44:2015-2019 (Pubitemid 24349498)
49. Amador-Ortiz C, Lin WL, Ahmed Z, Personett D, Davies P, Duara R, Graff-Radford NR, Hutton ML, Dickson DW (2007) TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease. Ann Neurol 61:435-445 (Pubitemid 46878771)
50. Yokota O, Tsuchiya K, Terada S, Ishizu H, Uchikado H, Ikeda M, Oyanagi K, Nakano I, Murayama S, Kuroda S, Akiyama H (2008) Basophilic inclusion body disease and neuronal intermediate filament inclusion disease: a comparative clinicopathological study. Acta Neuropathol 115:561-575
51. Yokota O, Tsuchiya K, Arai T, Yagishita S, Matsubara O, Mochizuki A, Tamaoka A, Kawamura M, Yoshida H, Terada S, Ishizu H, Kuroda S, Akiyama H (2009) Clinicopathological characterization of Pick's disease versus frontotemporal lobar degeneration with ubiquitin/TDP-43-positive inclusions. Acta Neuropathol 117:429-444
52. Kovacs GG, Majtenyi K, Spina S, Murrell JR, Gelpi E, Hoftberger R, Fraser G, Crowther RA, Goedert M, Budka H, Ghetti B (2008) White matter tauopathy with globular glial inclusions: a distinct sporadic frontotemporal lobar degeneration. J Neuropathol Exp Neurol 67:963-975
53. Yamada M (2003) Senile dementia of the neurofibrillary tangle type (tangle-only dementia): neuropathological criteria and clinical guidelines for diagnosis. Neuropathology 23:311-317
54. Wakisaka Y, Furuta A, Tanizaki Y, Kiyohara Y, Iida M, Iwaki T (2003) Age-associated prevalence and risk factors of Lewy body pathology in a general population: the Hisayama study. Acta Neuropathol 106:374-382 (Pubitemid 37265318)
55. Braak H, Thal DR, Ghebremedhin E, Del Tredici K (2011) Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. J Neuropathol Exp Neurol 70:960-969
56. Cummings JL (1985) Organic delusions: phenomenology, anatomical correlations, and review. Br J Psychiatry 146:184-197
57. Cummings JL, Mega MS (eds) (2003) Psychosis, delusion, and schizophrenia. In: Neuropsychiatry and behavioral neuroscience. Oxford University Press, New York, pp 172-186
58. McKeith IG, Perry RH, Fairbairn AF, Jabeen S, Perry EK (1992) Operational criteria for senile dementia of Lewy body type (SDLT). Psychol Med 22:911-922 (Pubitemid 23007002)
59. Aarsland D, Marsh L, Schrag A (2009) Neuropsychiatric symptoms in Parkinson's disease. Mov Disord 24:2175-2186
60. Aarsland D, Ballard C, Larsen JP, McKeith I (2001) A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson's disease with and without dementia. Int J Geriatr Psychiatry 16:528-536 (Pubitemid 32492388)
61. Perneczky R, Drzezga A, Boecker H, Förstl H, Kurz A, Häussermann P (2008) Cerebral metabolic dysfunction in patients with dementia with Lewy bodies and visual hallucinations. Dement Geriatr Cogn Disord 25:531-538 (Pubitemid 351957416)
62. Jellinger KA (2012) Cerebral correlates of psychotic syndromes in neurodegenerative diseases. J Cell Mol Med 2012(16):995-1012
63. Braak H, Del Tredici K, Rüb U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 24:197-211 (Pubitemid 36007810)
64. Remy P, Doder M, Lees A, Turjanski N, Brooks D (2005) Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain 128:1314-1322 (Pubitemid 40826185)
65. Diederich NJ, Leurgans S, Fan W, Chmura TA, Goetz CG (2008) Visual hallucinations and symptoms of REM sleep behavior disorder in Parkinsonian tauopathies. Int J Geriatr Psychiatry 23:598-603 (Pubitemid 351943844)
66. Yatabe Y, Hashimoto M, Kaneda K, Honda K, Ogawa Y, Yuuki S, Matsuzaki S, Tuyuguchi A, Kashiwagi H, Ikeda M (2011) Neuropsychiatric symptoms of progressive supranuclear palsy in a dementia clinic. Psychogeriatrics 11:54-59
67. Mollenhauer B, Locascio JJ, Schulz-Schaeffer W, Sixel-Döring F, Trenkwalder C, Schlossmacher MG (2011) α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study. Lancet Neurol 10:230-240
68. Luk C, Compta Y, Magdalinou N, Martí MJ, Hondhamuni G, Zetterberg H, Blennow K, Constantinescu R, Pijnenburg Y, Mollenhauer B, Trenkwalder C, Van Swieten J, Chiu WZ, Borroni B, Cámara A, Cheshire P, Williams DR, Lees AJ, de Silva R (2012) Development and assessment of sensitive immuno-PCR assays for the quantification of cerebrospinal fluid three- and four-repeat tau isoforms in tauopathies. J Neurochem 123:396-405
69. Foulds PG, Yokota O, Thurston A, Davidson Y, Ahmed Z, Holton J, Thompson JC, Akiyama H, Arai T, Hasegawa M, Gerhard A, Allsop D, Mann DM (2012) Post mortem cerebrospinal fluid α-synuclein levels are raised in multiple system atrophy and distinguish this from the other α-synucleinopathies, Parkinson's disease and Dementia with Lewy bodies. Neurobiol Dis 45:188-195